☰

Ross Zeitlin - Publications

Affiliations: 
2009-2012 VA Healthcare System, San Diego, CA, United States 
Tree Info Grants Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Echeverria V, Zeitlin R. Cotinine: a potential new therapeutic agent against Alzheimer's disease. Cns Neuroscience & Therapeutics. 18: 517-23. PMID 22530628 DOI: 10.1111/j.1755-5949.2012.00317.x  0.499
2012 Zeitlin R, Patel S, Solomon R, Tran J, Weeber EJ, Echeverria V. Cotinine enhances the extinction of contextual fear memory and reduces anxiety after fear conditioning. Behavioural Brain Research. 228: 284-93. PMID 22137886 DOI: 10.1016/j.bbr.2011.11.023  0.423
2011 Zeitlin R, Patel S, Burgess S, Arendash GW, Echeverria V. Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice. Brain Research. 1417: 127-36. PMID 21907331 DOI: 10.1016/J.Brainres.2011.08.036  0.623
2011 Echeverria V, Zeitlin R, Burgess S, Patel S, Barman A, Thakur G, Mamcarz M, Wang L, Sattelle DB, Kirschner DA, Mori T, Leblanc RM, Prabhakar R, Arendash GW. Cotinine reduces amyloid-β aggregation and improves memory in Alzheimer's disease mice. Journal of Alzheimer's Disease : Jad. 24: 817-35. PMID 21321389 DOI: 10.3233/Jad-2011-102136  0.636
2008 Citron BA, Dennis JS, Zeitlin RS, Echeverria V. Transcription factor Sp1 dysregulation in Alzheimer's disease. Journal of Neuroscience Research. 86: 2499-504. PMID 18449948 DOI: 10.1002/jnr.21695  0.403
Show low-probability matches.